Advisory Commission on Childhood Vaccines; Notice of Meeting, 22562 [E9-11084]

Download as PDF 22562 Federal Register / Vol. 74, No. 91 / Wednesday, May 13, 2009 / Notices Dated: May 5, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–11005 Filed 5–12–09; 8:45 am] BILLING CODE 4140–01–M comment period. These persons will be allocated time as it permits. For Further Information Contact: Anyone requiring information regarding the ACCV should contact Michelle Herzog, DVIC, HSB, HRSA, Room 11C–26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 443– 6593 or e-mail: mherzog@hrsa.gov. Dated: May 5, 2009. Alexandra Huttinger, Director, Division of Policy Review and Coordination. [FR Doc. E9–11084 Filed 5–12–09; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration BILLING CODE 4165–15–P Advisory Commission on Childhood Vaccines; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Commission on Childhood Vaccines (ACCV). Date and Time: June 4, 2009, 1 pm to 5:30 pm EDT. June 5, 2009, 9 a.m. to 12 p.m. EDT. Place: Parklawn Building (and via audio conference call), Conference Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857. The ACCV will meet on Thursday, June 4 from 1 pm to 5:30 pm (EDT) and Friday, June 5 from 9 a.m. to 12 p.m. (EDT). The public can join the meeting via audio conference call by dialing 1–888–790–1959 on June 4 & 5 and providing the following information: Leader’s Name: Dr. Geoffrey Evans. Password: ACCV. Agenda: The agenda items for the June meeting will include, but are not limited to: Updates from the Division of Vaccine Injury Compensation (DVIC), Department of Justice, National Vaccine Program Office, Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health), Center for Biologics, Evaluation and Research (Food and Drug Administration), an update from the IOM on the project to review adverse effects of vaccines, and a final report from Altarum Institute on the Petitioner’s Satisfaction Survey. Agenda items are subject to change as priorities dictate. Public Comments: Persons interested in providing an oral presentation should submit a written request, along with a copy of their presentation to: Michelle Herzog, DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 11C–26, 5600 Fishers Lane, Rockville, Maryland 20857 or e-mail: mherzog@hrsa.gov. Requests should contain the name, address, telephone number, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. DVIC will notify each presenter by mail or telephone of their assigned presentation time. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may announce it at the time of the VerDate Nov<24>2008 18:44 May 12, 2009 Jkt 217001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Task Force on Community Preventive Services In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Task Force on Community Preventive Services. Times and Dates: 8 a.m.–6 p.m. EST, June 17, 2009; 8 a.m.–1 p.m. EST, June 18, 2009. Place: Centers for Disease Control and Prevention, 2500 Century Parkway, Room 1200/1201, Atlanta, Georgia 30345. Status: Open to the public, limited only by the space available. Purpose: The mission of the Task Force is to develop and publish the Guide to Community Preventive Services (Community Guide), which consists of systematic reviews of the best available scientific evidence and associated recommendations regarding what works in the delivery of essential public health services. Topics include: —Interventions to increase vaccination coverage in children, adolescents, and adults: An Update ‘‘of’’ the vaccination requirements review —Using Population Levels of Alcohol Consumption as an Indicator of Excessive Alcohol Consumption and Related Harms —Group-based Interventions to Prevent Adolescent Pregnancy, HIV, Other Sexually Transmitted Infections: A Systematic Review and Meta-analyses —Update on the Community Guide Web site —VPD Updates: School-based Vaccination Programs —Mass Media Campaigns to Increase Physical Activity —Technology-based Strategies to Prevent and/or Control Obesity: Technology-based Multi-component Counseling Agenda items are subject to change as priorities dictate. Persons interested in reserving a space for this meeting should call Charmen Crawford at 404–498–2498. Contact person for additional information: Charmen Crawford, Coordinating Center for PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 Health Information and Services, National Center for Health Marketing, Office of the Director, 1600 Clifton Road, M/S E–69, Atlanta, GA 30329, phone: 404–498–2498. Dated: May 6, 2009. James D. Seligman, Chief Information Officer, Centers for Disease Control and Prevention. [FR Doc. E9–11138 Filed 5–12–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/ ATSDR) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC and NCEH/ ATSDR announce the following meeting of the aforementioned committee: Times and Dates: 8:30 a.m.–4 p.m., May 28, 2009. 8:30 a.m.–12:15 p.m., May 29, 2009. Place: Centers for Disease Control and Prevention, 4770 Buford Highway, Atlanta, Georgia 30341. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 75 people. Purpose: The Secretary, Department of Health and Human Services (HHS) and by delegation, the Director, CDC and Administrator, ATSDR, are authorized under Section 301 (42 U.S.C. 241) and Section 311 (42 U.S.C. 243) of the Public Health Service Act, as amended, to: (1) Conduct, encourage, cooperate with, and assist other appropriate public authorities, scientific institutions, and scientists in the conduct of research, investigations, experiments, demonstrations, and studies relating to the causes, diagnosis, treatment, control, and prevention of physical and mental diseases and other impairments; (2) assist states and their political subdivisions in the prevention of infectious diseases and other preventable conditions and in the promotion of health and well being; and (3) train state and local personnel in health work. The BSC, NCEH/ ATSDR provides advice and guidance to the Secretary, HHS; the Director, CDC and Administrator, ATSDR; and the Director, NCEH/ATSDR, regarding program goals, objectives, strategies, and priorities in fulfillment of the agency’s mission to protect and promote people’s health. The board provides advice and guidance that will assist NCEH/ATSDR in ensuring scientific quality, timeliness, utility, and dissemination of results. The board also provides guidance to help NCEH/ATSDR work more efficiently and effectively with its various constituents and to fulfill its mission in protecting America’s health. Matters To Be Discussed: The agenda items will include updates by the Director of E:\FR\FM\13MYN1.SGM 13MYN1

Agencies

[Federal Register Volume 74, Number 91 (Wednesday, May 13, 2009)]
[Notices]
[Page 22562]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-11084]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:

    Name: Advisory Commission on Childhood Vaccines (ACCV).
    Date and Time: June 4, 2009, 1 pm to 5:30 pm EDT. June 5, 2009, 
9 a.m. to 12 p.m. EDT.
    Place: Parklawn Building (and via audio conference call), 
Conference Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857.
    The ACCV will meet on Thursday, June 4 from 1 pm to 5:30 pm 
(EDT) and Friday, June 5 from 9 a.m. to 12 p.m. (EDT). The public 
can join the meeting via audio conference call by dialing 1-888-790-
1959 on June 4 & 5 and providing the following information:
    Leader's Name: Dr. Geoffrey Evans.
    Password: ACCV.
    Agenda: The agenda items for the June meeting will include, but 
are not limited to: Updates from the Division of Vaccine Injury 
Compensation (DVIC), Department of Justice, National Vaccine Program 
Office, Immunization Safety Office (Centers for Disease Control and 
Prevention), National Institute of Allergy and Infectious Diseases 
(National Institutes of Health), Center for Biologics, Evaluation 
and Research (Food and Drug Administration), an update from the IOM 
on the project to review adverse effects of vaccines, and a final 
report from Altarum Institute on the Petitioner's Satisfaction 
Survey. Agenda items are subject to change as priorities dictate.
    Public Comments: Persons interested in providing an oral 
presentation should submit a written request, along with a copy of 
their presentation to: Michelle Herzog, DVIC, Healthcare Systems 
Bureau (HSB), Health Resources and Services Administration (HRSA), 
Room 11C-26, 5600 Fishers Lane, Rockville, Maryland 20857 or e-mail: 
mherzog@hrsa.gov. Requests should contain the name, address, 
telephone number, and any business or professional affiliation of 
the person desiring to make an oral presentation. Groups having 
similar interests are requested to combine their comments and 
present them through a single representative. The allocation of time 
may be adjusted to accommodate the level of expressed interest. DVIC 
will notify each presenter by mail or telephone of their assigned 
presentation time. Persons who do not file an advance request for a 
presentation, but desire to make an oral statement, may announce it 
at the time of the comment period. These persons will be allocated 
time as it permits.
    For Further Information Contact: Anyone requiring information 
regarding the ACCV should contact Michelle Herzog, DVIC, HSB, HRSA, 
Room 11C-26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 
443-6593 or e-mail: mherzog@hrsa.gov.

    Dated: May 5, 2009.
Alexandra Huttinger,
Director, Division of Policy Review and Coordination.
[FR Doc. E9-11084 Filed 5-12-09; 8:45 am]
BILLING CODE 4165-15-P